Experts from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society contributed to the report, which noted that only about half of users continue taking their GLP-1 medication after one year and only about 15% remain on treatment after two years
When Side Effects Occur What to Do GI intolerance Hold dose escalation Step back to previous dose Small frequent meals Persistent vomiting Stop drug temporarily Hydrate Check renal function Suspected pancreatitis Severe epigastric pain STOP immediately Check amylase / lipase Evaluate urgently Final Clinical Takeaways Expect meaningful weight loss in the right patient, but not every patient loses equally Avoid DPP-4 inhibitors alongside semaglutide Switching from tirzepatide to semaglutide should be cautious
Conclusion GLP-1 medications offer a genuinely effective path to medical weight loss for patients who qualify, but how you do it matters
Semaglutide has been shown to reduce inflammation in other parts of the body, so it might also help reduce inflammation in the airways
Phentermine is not reported on the Semaglutide label as a potential drug interaction but its label has the caution mentioned for combining Phentermine with Semaglutide present in Ozempic and Rybelsus